[11C]Methionine emerges as a new biomarker for tracking active myeloma lesions.

MLA

Lapa, Constantin, et al. “[11C]Methionine Emerges as a New Biomarker for Tracking Active Myeloma Lesions.” British Journal of Haematology, vol. 181, no. 5, June 2018, pp. 701–03. EBSCOhost, https://doi.org/10.1111/bjh.14696.

APA

Lapa, C., Schreder, M., Lückerath, K., Samnick, S., Rudelius, M., Buck, A. K., Kortüm, K. M., Einsele, H., Rosenwald, A., & Knop, S. (2018). [11C]Methionine emerges as a new biomarker for tracking active myeloma lesions. British Journal of Haematology, 181(5), 701–703. https://doi.org/10.1111/bjh.14696

Chicago

Lapa, Constantin, Martin Schreder, Katharina Lückerath, Samuel Samnick, Martina Rudelius, Andreas K. Buck, Klaus M. Kortüm, Hermann Einsele, Andreas Rosenwald, and Stefan Knop. 2018. “[11C]Methionine Emerges as a New Biomarker for Tracking Active Myeloma Lesions.” British Journal of Haematology 181 (5): 701–3. doi:10.1111/bjh.14696.